SafebyDesign - a SaferWorldbyDesign InterAction Meeting

Tuesday 26 November 2019

10.00-10.45 East Coast, 16-16.45 CET - (7 am California, 10 am New York, 15.00 London, 16.00 Zurich, 20.30 New Delhi, 24.00 Tokyo)

Signup here

This virtual meeting will include a perspective by Christian Micheletti (TEMAS) on SafebyDesign methodology and a discussion session facilitated by Barry Hardy (Edelweiss Connect).

Safe by Design concept and implementation regarding complex substances

The Safe by Design (SbD) concept for nanomaterials and nano-enabled products has been developed by TEMAS and others under different flagship European initiatives to cover uncertainties and risks regarding the nanosize [1]. The concept helps innovators to be prepared for regulation and regulators to be prepared for innovation; establishing transparency and trust between innovators, regulators, and consumers. The final goal is to design safer products, applying the precautionary principle, so uncertainties and risk can be identified and managed as early as possible. The SbD concept enables the user to work independently at each phase of an innovation and development project. To materialise this concept, the Safe by Design Implementation Platform was developed by TEMAS as a web-based management structure, to support industry working with advanced materials both in processes and product development. The final aim is that safer products arrive on the market in a cost-efficient manner, always taking into account hazard and exposure issues to workers, consumers and environment. The application is regulatory-driven and fed by both hard regulations (REACH, Occupational Health, Cosmetics, Biocides, Pesticides) and soft regulations [Life Cycle Assessment (LCA) and Socio-Economic Analysis (SEA)] anticipating future requirements, so users are better prepared for upcoming regulations in a cost-efficient way. Examples of how to use the methodology in different developmental settings, innovation process stages and regulatory contexts will be provided.

[1] Kraegeloh A, Suarez-Merino B, Sluijters T and Micheletti C Nanomaterials 2018 (8) 239

Latest Tweets

Edelweiss Connect (Yesterday)
The goal of this webinar and discussion is to provide insight into the combined use of in silico and in vitro evide… https://t.co/W3hE1Cm95K
Edelweiss Connect (Yesterday)
#SaferWorldbyDesign presents: Skin safety assessment according to OECD guidelines Join us on December 17 for a we… https://t.co/oGymiPDVp0
Edelweiss Connect (2 days ago)
JRC Data Visualization: Extrapolating from acute to chronic toxicity in vitro An important question that was addre… https://t.co/B5Ius3qtDk
Edelweiss Connect (2 days ago)
#SaferWorldbyDesign webinar: In Silico solutions for drug discovery Presented by @Maieutix1 #insilico… https://t.co/Ya5J0ySQ0Q
Edelweiss Connect (2 weeks ago)
See why @wepredic @Biopredic_Intl #HepaRG™ cell model is the best for NAFLD investigations #SaferWorldbyDesign… https://t.co/pzgJbUhY7d

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA